With modern treatments for heart failure with reduced ejection fraction (EF), indicative of
impaired cardiac systolic function, patients may exhibit an increase in EF. Limited data are …

Patients with chronic kidney disease (CKD) are at high risk to develop cardiovascular
disease with its manifestations coronary artery disease, heart failure, arrhythmias, and …

Importance Dapagliflozin was recently shown to reduce cardiovascular death or worsening
heart failure (HF) events in patients with HF with mildly reduced or preserved ejection …

Aims Previously, guidelines recommended initiating therapy in patients with heart failure
and reduced ejection fraction (HFrEF) in a sequence that follows the chronological order in …

Heart failure (HF) and nonalcoholic fatty liver disease (NAFLD) are 2 conditions that have
become important global public health problems. Emerging evidence supports a strong and …

Excessive trabeculation, often referred to as “noncompacted” myocardium, has been
described at all ages, from the fetus to the adult. Current evidence for myocardial …

Cardiovascular disease (CVD) remains the leading cause of death worldwide, representing
a major health, social, and economic issue. Thyroid disorders are very common and affect> …

Many patients with symptoms and signs of heart failure have a left ventricular ejection
fraction≥ 50%, termed heart failure with preserved ejection fraction (HFpEF). HFpEF is a …

Lay Summary The cost of heart failure care is high owing to the cost of hospitalization and
chronic treatments. Heart failure treatments vary in their benefit and cost. The cost …

Myocarditis represents the entity of an inflamed myocardium and is a diagnostic challenge
caused by its heterogeneous presentation. Contemporary noninvasive evaluation of patients …